MBNL1 regulates essential alternative RNA splicing patterns in MLL-rearranged leukemia
Open Access
- 12 May 2020
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-14
Abstract
Despite growing awareness of the biologic features underlying MLL-rearranged leukemia, targeted therapies for this leukemia have remained elusive and clinical outcomes remain dismal. MBNL1, a protein involved in alternative splicing, is consistently overexpressed in MLL-rearranged leukemias. We found that MBNL1 loss significantly impairs propagation of murine and human MLL-rearranged leukemia in vitro and in vivo. Through transcriptomic profiling of our experimental systems, we show that in leukemic cells, MBNL1 regulates alternative splicing (predominantly intron exclusion) of several genes including those essential for MLL-rearranged leukemogenesis, such as DOT1L and SETD1A. We finally show that selective leukemic cell death is achievable with a small molecule inhibitor of MBNL1. These findings provide the basis for a new therapeutic target in MLL-rearranged leukemia and act as further validation of a burgeoning paradigm in targeted therapy, namely the disruption of cancer-specific splicing programs through the targeting of selectively essential RNA binding proteins.Keywords
Funding Information
- CancerFree KIDS
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (R50 CA211404, R01 CA226802)
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
- St. Baldrick's Foundation
- Cincinnati Children's Research Foundation
- U.S. Department of Health & Human Services | NIH | Division of Loan Repayment (L40 HL143713-01)
This publication has 66 references indexed in Scilit:
- MBNL proteins repress ES-cell-specific alternative splicing and reprogrammingNature, 2013
- RUNX1 Is a Key Target in t(4;11) Leukemias that Contributes to Gene Activation through an AF4-MLL Complex InteractionCell Reports, 2013
- CUGBP1 and MBNL1 preferentially bind to 3′ UTRs and facilitate mRNA decayScientific Reports, 2012
- MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1LCancer Cell, 2011
- GSK-3 Promotes Conditional Association of CREB and Its Coactivators with MEIS1 to Facilitate HOX-Mediated Transcription and OncogenesisCancer Cell, 2010
- Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell IdentitiesMolecular Cell, 2010
- Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophyNature Structural & Molecular Biology, 2010
- Microenvironment Determines Lineage Fate in a Human Model of MLL-AF9 LeukemiaCancer Cell, 2008
- Malignant Transformation Initiated by Mll-AF9: Gene Dosage and Critical Target CellsCancer Cell, 2008
- Muscleblind proteins regulate alternative splicingThe EMBO Journal, 2004